Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico

Paulina Gomez-Rubio, Jason Roberge, Leslie Arendell, Robin B Harris, Mary Kay O'Rourke, Zhao Chen, Ernesto Cantu-Soto, Maria M. Meza-Montenegro, David D Billheimer, Zhenqiang Lu, Walter Klimecki

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Human arsenic methylation efficiency has been consistently associated with arsenic-induced disease risk. Interindividual variation in arsenic methylation profiles is commonly observed in exposed populations, and great effort has been put into the study of potential determinants of this variability. Among the factors that have been evaluated, body mass index (BMI) has not been consistently associated with arsenic methylation efficiency; however, an underrepresentation of the upper BMI distribution was commonly observed in these studies. This study investigated potential factors contributing to variations in the metabolism of arsenic, with specific interest in the effect of BMI where more than half of the population was overweight or obese. We studied 624 adult women exposed to arsenic in drinking water from three independent populations. Multivariate regression models showed that higher BMI, arsenic (+. 3 oxidation state) methyltransferase (AS3MT) genetic variant 7388, and higher total urinary arsenic were significantly associated with low percentage of urinary arsenic excreted as monomethylarsonic acid (%uMMA) or high ratio between urinary dimethylarsinic acid and uMMA (uDMA/uMMA), while AS3MT genetic variant M287T was associated with high %uMMA and low uDMA/uMMA. The association between BMI and arsenic methylation efficiency was also evident in each of the three populations when studied separately. This strong association observed between high BMI and low %uMMA and high uDMA/uMMA underscores the importance of BMI as a potential arsenic-associated disease risk factor, and should be carefully considered in future studies associating human arsenic metabolism and toxicity.

Original languageEnglish (US)
Pages (from-to)176-182
Number of pages7
JournalToxicology and Applied Pharmacology
Volume252
Issue number2
DOIs
StatePublished - Apr 15 2011

Fingerprint

Southwestern United States
Methylation
Arsenic
Mexico
Body Mass Index
Cacodylic Acid
Metabolism
Population
Association reactions
Methyltransferases
Drinking Water

Keywords

  • Arsenic
  • Arsenic metabolism
  • AS3MT
  • BMI
  • Body mass index
  • Genetic association

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. / Gomez-Rubio, Paulina; Roberge, Jason; Arendell, Leslie; Harris, Robin B; O'Rourke, Mary Kay; Chen, Zhao; Cantu-Soto, Ernesto; Meza-Montenegro, Maria M.; Billheimer, David D; Lu, Zhenqiang; Klimecki, Walter.

In: Toxicology and Applied Pharmacology, Vol. 252, No. 2, 15.04.2011, p. 176-182.

Research output: Contribution to journalArticle

Gomez-Rubio, Paulina ; Roberge, Jason ; Arendell, Leslie ; Harris, Robin B ; O'Rourke, Mary Kay ; Chen, Zhao ; Cantu-Soto, Ernesto ; Meza-Montenegro, Maria M. ; Billheimer, David D ; Lu, Zhenqiang ; Klimecki, Walter. / Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. In: Toxicology and Applied Pharmacology. 2011 ; Vol. 252, No. 2. pp. 176-182.
@article{1e8debcbe4494aaa98690e3040089f0c,
title = "Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico",
abstract = "Human arsenic methylation efficiency has been consistently associated with arsenic-induced disease risk. Interindividual variation in arsenic methylation profiles is commonly observed in exposed populations, and great effort has been put into the study of potential determinants of this variability. Among the factors that have been evaluated, body mass index (BMI) has not been consistently associated with arsenic methylation efficiency; however, an underrepresentation of the upper BMI distribution was commonly observed in these studies. This study investigated potential factors contributing to variations in the metabolism of arsenic, with specific interest in the effect of BMI where more than half of the population was overweight or obese. We studied 624 adult women exposed to arsenic in drinking water from three independent populations. Multivariate regression models showed that higher BMI, arsenic (+. 3 oxidation state) methyltransferase (AS3MT) genetic variant 7388, and higher total urinary arsenic were significantly associated with low percentage of urinary arsenic excreted as monomethylarsonic acid ({\%}uMMA) or high ratio between urinary dimethylarsinic acid and uMMA (uDMA/uMMA), while AS3MT genetic variant M287T was associated with high {\%}uMMA and low uDMA/uMMA. The association between BMI and arsenic methylation efficiency was also evident in each of the three populations when studied separately. This strong association observed between high BMI and low {\%}uMMA and high uDMA/uMMA underscores the importance of BMI as a potential arsenic-associated disease risk factor, and should be carefully considered in future studies associating human arsenic metabolism and toxicity.",
keywords = "Arsenic, Arsenic metabolism, AS3MT, BMI, Body mass index, Genetic association",
author = "Paulina Gomez-Rubio and Jason Roberge and Leslie Arendell and Harris, {Robin B} and O'Rourke, {Mary Kay} and Zhao Chen and Ernesto Cantu-Soto and Meza-Montenegro, {Maria M.} and Billheimer, {David D} and Zhenqiang Lu and Walter Klimecki",
year = "2011",
month = "4",
day = "15",
doi = "10.1016/j.taap.2011.02.007",
language = "English (US)",
volume = "252",
pages = "176--182",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico

AU - Gomez-Rubio, Paulina

AU - Roberge, Jason

AU - Arendell, Leslie

AU - Harris, Robin B

AU - O'Rourke, Mary Kay

AU - Chen, Zhao

AU - Cantu-Soto, Ernesto

AU - Meza-Montenegro, Maria M.

AU - Billheimer, David D

AU - Lu, Zhenqiang

AU - Klimecki, Walter

PY - 2011/4/15

Y1 - 2011/4/15

N2 - Human arsenic methylation efficiency has been consistently associated with arsenic-induced disease risk. Interindividual variation in arsenic methylation profiles is commonly observed in exposed populations, and great effort has been put into the study of potential determinants of this variability. Among the factors that have been evaluated, body mass index (BMI) has not been consistently associated with arsenic methylation efficiency; however, an underrepresentation of the upper BMI distribution was commonly observed in these studies. This study investigated potential factors contributing to variations in the metabolism of arsenic, with specific interest in the effect of BMI where more than half of the population was overweight or obese. We studied 624 adult women exposed to arsenic in drinking water from three independent populations. Multivariate regression models showed that higher BMI, arsenic (+. 3 oxidation state) methyltransferase (AS3MT) genetic variant 7388, and higher total urinary arsenic were significantly associated with low percentage of urinary arsenic excreted as monomethylarsonic acid (%uMMA) or high ratio between urinary dimethylarsinic acid and uMMA (uDMA/uMMA), while AS3MT genetic variant M287T was associated with high %uMMA and low uDMA/uMMA. The association between BMI and arsenic methylation efficiency was also evident in each of the three populations when studied separately. This strong association observed between high BMI and low %uMMA and high uDMA/uMMA underscores the importance of BMI as a potential arsenic-associated disease risk factor, and should be carefully considered in future studies associating human arsenic metabolism and toxicity.

AB - Human arsenic methylation efficiency has been consistently associated with arsenic-induced disease risk. Interindividual variation in arsenic methylation profiles is commonly observed in exposed populations, and great effort has been put into the study of potential determinants of this variability. Among the factors that have been evaluated, body mass index (BMI) has not been consistently associated with arsenic methylation efficiency; however, an underrepresentation of the upper BMI distribution was commonly observed in these studies. This study investigated potential factors contributing to variations in the metabolism of arsenic, with specific interest in the effect of BMI where more than half of the population was overweight or obese. We studied 624 adult women exposed to arsenic in drinking water from three independent populations. Multivariate regression models showed that higher BMI, arsenic (+. 3 oxidation state) methyltransferase (AS3MT) genetic variant 7388, and higher total urinary arsenic were significantly associated with low percentage of urinary arsenic excreted as monomethylarsonic acid (%uMMA) or high ratio between urinary dimethylarsinic acid and uMMA (uDMA/uMMA), while AS3MT genetic variant M287T was associated with high %uMMA and low uDMA/uMMA. The association between BMI and arsenic methylation efficiency was also evident in each of the three populations when studied separately. This strong association observed between high BMI and low %uMMA and high uDMA/uMMA underscores the importance of BMI as a potential arsenic-associated disease risk factor, and should be carefully considered in future studies associating human arsenic metabolism and toxicity.

KW - Arsenic

KW - Arsenic metabolism

KW - AS3MT

KW - BMI

KW - Body mass index

KW - Genetic association

UR - http://www.scopus.com/inward/record.url?scp=79953720248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953720248&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2011.02.007

DO - 10.1016/j.taap.2011.02.007

M3 - Article

C2 - 21320519

AN - SCOPUS:79953720248

VL - 252

SP - 176

EP - 182

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -